Author Archives: jewett sam

Oral GLP-1 vs Injection: What Is the Difference?

Interest in oral GLP-1 products has increased as new tablet formulations and indications have reached [...]

What Is GLP-1 Microdosing, and Is It Evidence-Based?

“GLP-1 microdosing” is an online term generally used for amounts below a product’s labeled treatment [...]

Do GLP-1 Medications Need to Be Stopped Before Surgery?

Questions about GLP-1 medicines before surgery remain highly searched because professional guidance has evolved. The [...]

Are Compounded GLP-1 Products the Same as FDA-Approved Drugs?

No. FDA-approved medicines undergo agency review for safety, effectiveness, manufacturing quality and labeling. Compounded drugs [...]

Can You Drink Alcohol While Taking a GLP-1 Medication?

There is no single alcohol rule that applies to every GLP-1 product or patient. The [...]

CJC-1295 vs Ipamorelin: What Is the Difference in Research?

CJC-1295 and ipamorelin are frequently mentioned together, but they are different experimental peptides that interact [...]

What Is MOTS-c, and Why Is It Studied in Metabolic Research?

MOTS-c is a mitochondrial-derived peptide that has attracted interest in metabolism, cellular stress and healthy-aging [...]

What Is BPC-157, and What Does the Research Actually Show?

BPC-157 is an experimental synthetic peptide frequently discussed in relation to gastrointestinal and tissue-repair research. [...]

Understanding Tirzepatide Vials: Concentration and Purity

A vial label can list a compound name and nominal quantity, but those details alone [...]

BPC-157 vs TB-500: How Are These Research Peptides Different?

“BPC-157 vs TB-500” is a popular search because both compounds appear in online conversations about [...]